Thomas O. Daniel
2015
In 2015, Thomas O. Daniel earned a total compensation of $7.3M as Chairman, Celgene Research at Celgene, a 4% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,075,016 |
|---|---|
| Option Awards | $1,405,470 |
| Salary | $717,500 |
| Stock Awards | $1,969,451 |
| Other | $174,541 |
| Total | $7,341,978 |
Daniel received $3.1M in non-equity incentive plan, accounting for 42% of the total pay in 2015.
Daniel also received $1.4M in option awards, $717.5K in salary, $2M in stock awards and $174.5K in other compensation.
Rankings
In 2015, Thomas O. Daniel's compensation ranked 905th out of 13,638 executives tracked by ExecPay. In other words, Daniel earned more than 93.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 905 out of 13,638 | 93rd |
Division Manufacturing | 312 out of 5,187 | 94th |
Major group Chemicals And Allied Products | 114 out of 1,857 | 94th |
Industry group Drugs | 88 out of 1,531 | 94th |
Industry Pharmaceutical Preparations | 72 out of 1,179 | 94th |
Source: SEC filing on April 28, 2016.
Daniel's colleagues
We found five more compensation records of executives who worked with Thomas O. Daniel at Celgene in 2015.